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Case 1
A full-term infant girl was delivered by elective caesare-
an section at 38 + 3 gestational weeks. Pregnancy histo-
ry was unremarkable.  Birth weight: 3465 grams. Apgar 
score was 9, 10, and 10 at 1, 5, and 10 min, respectively. 
There were no complications in the immediate neonatal 
period. On the fifth day of life, an erythematous, hard, 
and painless lesion (2 × 2 cm) in the right upper limb 
was detected (Fig. 1). Ultrasound revealed thickening 
and hyperechogenicity of the subcutaneous cellular 
tissue, compatible with subcutaneous fat necrosis 
(SCFN). Initial laboratorial studies were unremarkable, 
except mildly increased ionized calcium 5.53 mg/dL 
(reference range: 4.8–5.52 mg/dL). The patient did not 
receive vitamin D supplements. Subsequent laboratorial 
studies revealed no changes. There was spontaneous 
progressive reduction of the lesion and complete disap-
pearance at 6 months.
Case 2
A female term newborn was delivered by elective 
caesarean section at 38 weeks following an uncompli-
cated pregnancy. Birth weight: 3700 g. Apgar score was 
10,10,and 10 at 1, 5, and 10 min, respectively. At birth, 
she had an erythematous, hard, and painless lesion 
in the left upper limb (3 × 3 cm) (Fig. 2). Ultrasound 
showed heterogeneous and hyperechoic thickening 
of the subcutaneous cell tissue, with 2-mm cystic areas 
compatible with SCFN. Before discharge, blood tests 
performed showed mild hypercalcaemia (calcium 
11.6 mg/dL; reference 7.6–10.4mg/dL) and decreased 
parathyroid hormone (9.9 pg/mL; reference 15–65 
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Figure 2. Subcutaneous fat necrosis (SCFN) localized on the 
left arm 
Figure 1aB. Subcutaneous fat necrosis (SCFN) hard nodules 
covered by erythematous skin, localized in the right arm
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Hypercalcaemia is the main complication of this 
pathology; it is found in 25–50% of the cases and may 
be present before the subcutaneous nodules appear. 
In a systematic review of published cases of SCFN, 
hypercalcaemia was detected in 57% in the first 28 
days of life and in 30% in the following 28 days. This 
complication appears 1–6 months after SCFN, and 
therefore monitoring serum calcium levels is essential. 
Since regression of the lesions is usually associated with 
an increase in serum calcium levels, some authors rec-
ommend monitoring them at 30, 45, and 60 days after 
the disappearance of skin lesions [1]. The pathogenesis 
of the hypercalcaemia is also not understood. Granu-
lomatous inflammatory cells in SCFN express high 
levels of 1-alpha-hydroxylase, the enzyme that converts 
25-hydroxyvitamin D3 to its active form of 1,25-dihy-
droxyvitamin D3. 1,25-dihydroxyvitamin D3 promotes 
calcium mobilization from bone and increases intestinal 
absorption of calcium. Therefore, it is plausible that in-
creased 1,25-dihydroxyvitamin D3 production in affect-
ed tissue of SCFN results in secondary hypercalcaemia 
[4]. Increased prostaglandin E or parathyroid hormone 
levels have been postulated; however, they are often 
normal in these infants [5]. Additionally, it has been sug-
gested that decreased renal clearance of calcium may 
contribute to SCFN-associated hypercalcaemia. These 
changes are important since failure to implement prompt 
therapy, including restriction of supplemental calcium 
and vitamin D, hyperhydration with intravenous fluids, 
and calcium-wasting loop diuretics can lead to severe 
complications such as nephrolithiasis and acute renal 
injury. In more severe cases, systemic corticosteroids and 
bisphosphonates have been used. When SCFN is not 
associated with hypercalcaemia, the treatment of this 
dermatosis is symptomatic, requiring the avoidance of 
vitamin D supplementation [1–3].
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pg/mL). She was not supplemented with vitamin D. 
During follow-up she maintained hypercalcaemia 
(10.8 mg/dL) and was referred to the Paediatric En-
docrinology Clinic for evaluation. At 5 months of age, 
calcium and 25-OH-vitamin D values were normal, 
and the lesion decreased. At 9 months, the baby was 
in good clinical condition and the lesion disappeared.
Subcutaneous fat necrosis of the newborn is an un-
common disorder, with self-limiting panniculitis present-
ing in the first few weeks after birth as wide erythema-
tous plaques or firm non-tender subcutaneous nodules, 
which most commonly affect the limbs, buttocks, back, 
cheeks, and areas over bony prominences [1, 2]. 
The aetiology and pathogenesis of SCFN is un-
known. It is postulated that subcutaneous tissue hy-
poperfusion aggravates the deposition of saturated fatty 
acids, and because the system enzymes are immature 
there is increasing deposition of saturated fatty acids, 
leading to adipose tissue solidification and necrosis. The 
local pressure resulting from childbirth trauma can 
increase the tendency to fat necrosis [3].
The diagnosis is clinical, suggested by history and 
characteristic clinical findings. Imaging exams are 
generally unnecessary for diagnosis, although they 
play an important role in excluding other causes be-
cause the presence of soft tissue swelling in newborns 
requires a detailed investigation [5]. Skin biopsy is not 
necessary to establish the diagnosis, especially if there 
are no concerns about the differential diagnosis. In our 
2 cases, clinical evaluation together with non-invasive 
imaging were essential for timely recognition, without 
the need for biopsy.
The most important differential diagnosis is scler-
ema neonatorum, a disorder in which there is a thick-
ening of the skin secondary to fibrosis of the trabecular 
septa of the adipocytes’ involvement of the muscle and 
bone tissue, associated with congenital malformations, 
cyanosis, respiratory disorders, and sepsis [3]. Another 
differential diagnosis is scleredema, which presents 
progressive oedema of the extremities and stiffening of 
the affected limbs, usually preceded by gastrointestinal 
or respiratory infections; pathology reveals intense 
interstitial oedema associated with lobular panniculitis 
without vasculitis. Other differential diagnosis includes 
skin infections, CMV infection, haemangiomas, Farber 
disease, and sarcomas [1, 3].
This is a benign condition which usually resolves 
spontaneously in less than a year. However, it can 
be accompanied by extracutaneous changes, namely 
hypoglycaemia, anaemia, thrombocytopaenia, and 
hypercalcaemia. 
